These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18400496)

  • 1. Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.
    Whitlock GA; Conlon K; McMurray G; Roberts LR; Stobie A; Thurlow RJ
    Bioorg Med Chem Lett; 2008 May; 18(9):2930-4. PubMed ID: 18400496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.
    Whitlock GA; Brennan PE; Roberts LR; Stobie A
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3118-21. PubMed ID: 19394220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 2-imidazoles as potent, selective and CNS penetrant alpha1A adrenoceptor partial agonists.
    Roberts LR; Bryans J; Conlon K; McMurray G; Stobie A; Whitlock GA
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6437-40. PubMed ID: 18980842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.
    Roberts LR; Fish PV; Ian Storer R; Whitlock GA
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3113-7. PubMed ID: 19414260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized crossover study to evaluate RO 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.
    Wein AJ
    BJU Int; 2004 Jun; 93(9):1361. PubMed ID: 15180647
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist.
    Altenbach RJ; Khilevich A; Kolasa T; Rohde JJ; Bhatia PA; Patel MV; Searle XB; Yang F; Bunnelle WH; Tietje K; Bayburt EK; Carroll WA; Meyer MD; Henry R; Buckner SA; Kuk J; Daza AV; Milicic IV; Cain JC; Kang CH; Ireland LM; Carr TL; Miller TR; Hancock AA; Nakane M; Esbenshade TA; Brune ME; O'Neill AB; Gauvin DM; Katwala SP; Holladay MW; Brioni JD; Sullivan JP
    J Med Chem; 2004 Jun; 47(12):3220-35. PubMed ID: 15163201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of 2-((R-5-chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a novel and selective alpha1A-adrenergic partial agonist, in in vitro and in vivo models of urethral function.
    Conlon K; Christy C; Westbrook S; Whitlock G; Roberts L; Stobie A; McMurray G
    J Pharmacol Exp Ther; 2009 Sep; 330(3):892-901. PubMed ID: 19498105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized crossover study to evaluate Ro 115-1240, a selective alpha-adrenoceptor partial agonist in women with stress urinary incontinence.
    Wein AJ
    BJU Int; 2004 May; 93(7):1115. PubMed ID: 15142177
    [No Abstract]   [Full Text] [Related]  

  • 9. (Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3930-4. PubMed ID: 17517507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha(1) adrenoceptor subtype selectivity. 3D-QSAR models for a new class of alpha(1) adrenoceptor antagonists derived from the novel antipsychotic sertindole.
    Balle T; Andersen K; Søby KK; Liljefors T
    J Mol Graph Model; 2003 Jun; 21(6):523-34. PubMed ID: 12676239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medetomidine analogs as alpha 2-adrenergic ligands. 3. Synthesis and biological evaluation of a new series of medetomidine analogs and their potential binding interactions with alpha 2-adrenoceptors involving a "methyl pocket".
    Zhang X; De Los Angeles JE; He MY; Dalton JT; Shams G; Lei L; Patil PN; Feller DR; Miller DD; Hsu FL
    J Med Chem; 1997 Sep; 40(19):3014-24. PubMed ID: 9301663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 2-[(5-methylbenz-1-ox-4-azin-6-yl)imino]imidazoline, a potent, peripherally acting alpha 2 adrenoceptor agonist.
    Munk SA; Harcourt D; Ambrus G; Denys L; Gluchowski C; Burke JA; Kharlamb AB; Manlapaz CA; Padillo EU; Runde E; Williams L; Wheeler LA; Garst ME
    J Med Chem; 1996 Aug; 39(18):3533-8. PubMed ID: 8784451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.
    Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R
    Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3292-7. PubMed ID: 17452102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro characterization of N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8- tetrahydronaphthalen-1-yl]methanesulfonamide and its enantiomers: a novel selective alpha 1A receptor agonist.
    Meyer MD; Altenbach RJ; Hancock AA; Buckner SA; Knepper SM; Kerwin JF
    J Med Chem; 1996 Sep; 39(20):4116-9. PubMed ID: 8831777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1-adrenergic receptor agonist activity of clinical alpha-adrenergic receptor agonists interferes with alpha-2-mediated analgesia.
    Gil DW; Cheevers CV; Kedzie KM; Manlapaz CA; Rao S; Tang E; Donello JE
    Anesthesiology; 2009 Feb; 110(2):401-7. PubMed ID: 19194166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine.
    Altenbach RJ; Khilevich A; Meyer MD; Buckner SA; Milicic I; Daza AV; Brune ME; O'Neill AB; Gauvin DM; Cain JC; Nakane M; Holladay MW; Williams M; Brioni JD; Sullivan JP
    J Med Chem; 2002 Sep; 45(20):4395-7. PubMed ID: 12238918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.
    Bishop MJ; Barvian KA; Berman J; Bigham EC; Garrison DT; Gobel MJ; Hodson SJ; Irving PE; Liacos JA; Navas F; Saussy DL; Speake JD
    Bioorg Med Chem Lett; 2002 Feb; 12(3):471-5. PubMed ID: 11814822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis, and biological activity of conformationally restricted naphthalene derivatives of medetomidine.
    Zhang X; Yao XT; Dalton JT; Shams G; Lei L; Patil PN; Feller DR; Hsu FL; George C; Miller DD
    J Med Chem; 1996 Jul; 39(15):3001-13. PubMed ID: 8709134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):640-4. PubMed ID: 18055202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.